HopeStage
Back to all studies
RecruitingNCT06641726

Genetic and health data to study bipolarity, psychosis, depression and dementia

About this titleRead the official source — NCT06641726
Observational studyAges 18–110United Kingdom
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 110 years.

Listed locations
OxfordSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: May 16, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
50,000
Sponsor
Akrivia Health
Sponsor type
Unknown or unclear
Study type
Observational
Intervention type
Other
Locations
United Kingdom
Age range
From 18 Years to 110 Years
Official registry ID
NCT06641726
Official title
Show the full official title

Developing an Internationally-diverse, Linked Genomic and Longitudinal Phenotypic Research Dataset to Accelerate Precision Psychiatry for Patients With Serious Mental Illness

Recruitment & locations

Currently recruiting

Oxford

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Akrivia Health.

Who can participate?

Listed age limits: 18 years to 110 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies